MyFinsight
Home
Blog
About
Contact
Download
Download image
Other current assets
$6,893K
Other royalty income
receivable
$29,316K
Available for sale debt
securities
$18,800K
Financial royalty assets
$854,386K
Cash and cash
equivalents
$618,696K
Other assets
$79,293K
Goodwill
$924,634K
Equity method
investments
$289,968K
Available for sale debt
securities
$419,000K
Equity securities
$171,312K
Financial royalty assets,
net
$16,208,482K
Total current assets
$1,528,091K
Total assets
$19,620,780K
Total liabilities and
shareholders equity
$19,620,780K
Total shareholders
equity
$9,714,939K
Total liabilities
$9,905,841K
Treasury interests
$2,612K
Non-controlling interests
$3,238,039K
Retained earnings
$2,356,318K
Additional paid-in capital
$4,123,088K
Other liabilities
$120,843K
Accrued compensation
liabilities
$577,870K
Long-term debt
$8,570,917K
Total current
liabilities
$636,211K
Common stock-Class
RRedeemable Stock
$63K
Common stock-Common
Class A
$43K
Other current
liabilities
$53,164K
Current portion of
long-term debt
$380,000K
Interest payable
$110,818K
Accounts payable and
accrued expenses
$19,404K
Distributions payable to
legacy...
$72,825K
Back
Back
Balance Sheet
source: myfinsight.com
1-svg
Royalty Pharma plc (RPRX)
1-svg
Royalty Pharma plc (RPRX)